Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- CytomX Therapeutics is a biotechnology company focused on revolutionizing the monoclonal antibody field by creating a new generation of highly targeted antibody therapeutics. CytomX's novel Probody™ Platform offers a highly differentiated approach to developing antibody therapeutics, and is based on a robust and growing intellectual property estate.
- Market
- Monoclonal Antibody Therapeutics
- Coinvestors
- Canaan Partners, Pfizer Strategic Investments Group, Third Rock Ventures
Links